BTC $76,770.33 -1.33%
ETH $2,383.08 -2.43%
BNB $683.94 -0.27%
XRP $1.32 -3.02%
SOL $97.91 -3.82%
TRX $0.3234 -0.90%
DOGE $0.0809 -1.79%
ADA $0.1945 -1.55%
BCH $243.74 -1.40%
LINK $11.01 -3.36%
HYPE $80.98 -3.04%
AAVE $126.34 +0.25%
SUI $0.7125 -1.84%
XLM $0.1723 -3.07%
ZEC $798.04 -5.78%
BTC $76,770.33 -1.33%
ETH $2,383.08 -2.43%
BNB $683.94 -0.27%
XRP $1.32 -3.02%
SOL $97.91 -3.82%
TRX $0.3234 -0.90%
DOGE $0.0809 -1.79%
ADA $0.1945 -1.55%
BCH $243.74 -1.40%
LINK $11.01 -3.36%
HYPE $80.98 -3.04%
AAVE $126.34 +0.25%
SUI $0.7125 -1.84%
XLM $0.1723 -3.07%
ZEC $798.04 -5.78%

US stock MEIP rose over 33% today, with a market value reaching 41.24 million USD

2025-07-19 00:18:45

ChainCatcher news, according to market news, MEI Pharma (NASDAQ: MEIP) rose over 33% today, with a market capitalization reaching $41.2431 million.

Previously, it was reported that Titan Partners Group and crypto investment firm GSR are jointly leading a strategic transformation for the American pharmaceutical company MEI Pharma (NASDAQ: MEIP), promoting the establishment of a dedicated Litecoin treasury strategy. Currently, over $100 million in funding commitments have been made for this project. Litecoin founder Charlie Lee has agreed to join the board of MEI Pharma.

app_icon
ChainCatcher Building the Web3 world with innovations.